Background: Few studies have examined recent temporal trends in self-reported receipt of pelvic inflammatory disease (PID) treatment. We assessed trends in receipt of PID treatment and associated correlates using national survey data.
Methods: We used data from the National Survey of Family Growth, a multistage national probability survey of 15- to 44-year-old women. We examined trends in self-reported receipt of PID treatment from 1995, 2002, to 2006–2010. In addition, we examined correlates of PID treatment in 1995 and 2006–2010 in bivariate and adjusted analyses.
Results: From 1995 to 2002, receipt of PID treatment significantly declined from 8.6% to 5.7% (P < 0.0001); however, there was no difference from 2002 to 2006–2010 (5.0%, P = 0.16). In bivariate analyses, racial differences in PID treatment declined across time; in 2006–2010, there was no significant difference between racial/ethnic groups (P = 0.22). Also in bivariate analyses, similar to 1995, in 2006 to 2010, some of the highest reports of receipt of PID treatment were women who were 35 to 44 years old (5.6%), had an income less than 150% of poverty level (7.5%), had less than high school education (6.7%), douched (7.7%), had intercourse before age 15 years (10.3%), and had 10 or more lifetime partners (8.0%). In adjusted analyses, differing from 1995, women at less than 150% of the poverty level were more likely (adjusted odds ratio [AOR], 2.60; 95% confidence interval [CI], 1.79–3.76) than women at 300% or more of the poverty level to have received PID treatment in 2006–2010.
Conclusions: Receipt of PID treatment declined from 1995 to 2006–2010, with the burden affecting women of lower socioeconomic status.
Data from a national probability sample of reproductive-aged women found a decrease in receipt of treatment for pelvic inflammatory disease from 1995 to 2006&#x2013;2010, but treatment was highest among women with a lower socioeconomic status.
From the *Division of STD Prevention, and †National Center for Health Statistics (Hyattsville, MD), Centers for Disease Control and Prevention, Atlanta, GA
Conflicts of interest and source of funding. None.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Correspondence: Jami S. Leichliter, PhD, Division of STD Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd, MS E-44, Atlanta, GA 30333. E-mail: firstname.lastname@example.org.
Received for publication September 14, 2012, and accepted December 18, 2012.